Mark Brosius Sells 22 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 22 shares of Intuitive Surgical stock in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $563.00, for a total value of $12,386.00. Following the completion of the transaction, the senior vice president now owns 2,025 shares of the company’s stock, valued at $1,140,075. The trade was a 1.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Mark Brosius also recently made the following trade(s):

• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The shares were sold at an average price of $551.97, for a total value of $12,143.34.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The shares were sold at an average price of $533.18, for a total value of $260,725.02.
• On Wednesday, March 5th, Mark Brosius sold 492 shares of Intuitive Surgical stock. The stock was sold at an average price of $554.17, for a total value of $272,651.64.
• On Monday, March 3rd, Mark Brosius sold 492 shares of Intuitive Surgical stock. The stock was sold at an average price of $573.78, for a total value of $282,299.76.

Intuitive Surgical Trading Down 1.0%

Shares of NASDAQ ISRG opened at $560.28 on Friday. The stock has a market cap of $200.81 billion, a P/E ratio of 87.41, a P/E/G ratio of 5.85 and a beta of 1.70. The stock has a 50 day moving average of $503.82 and a two-hundred day moving average of $536.13. Intuitive Surgical, Inc. has a twelve month low of $393.98 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the previous year, the company posted $1.50 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $82,517,000. Sycomore Asset Management increased its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. increased its holdings in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the period. Finally, Brookstone Capital Management grew its holdings in Intuitive Surgical by 25.4% during the fourth quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider’s stock worth $9,448,000 after acquiring an additional 3,663 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on ISRG shares. CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Jefferies Financial Group boosted their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Truist Financial decreased their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.